The GABA B (γ-aminobutyric acid type B) receptor is one of the principal inhibitory neurotransmitter receptors in the brain, and it signals through heterotrimeric G proteins to activate a variety of effectors, including G-protein-coupled inwardly rectifying potassium channels (GIRKs) 1,2 . GABA B -receptor signalling is tightly regulated by auxiliary subunits called KCTDs, which control the kinetics of GIRK activation and desensitization 3-5 . However, the mechanistic basis for KCTD modulation of GABA B signalling remains incompletely understood. Here, using a combination of X-ray crystallography, electron microscopy, and functional and biochemical experiments, we reveal the molecular details of KCTD binding to both GABA B receptors and G-protein βγ subunits. KCTDs associate with the receptor by forming an asymmetric pentameric ring around a region of the receptor carboxy-terminal tail, while a second KCTD domain, H1, engages in a symmetric interaction with five copies of Gβγ in which the G-protein subunits also interact directly with one another. We further show that KCTD binding to Gβγ is highly cooperative, defining a model in which KCTD proteins cooperatively strip G proteins from GIRK channels to induce rapid desensitization following receptor activation. These results provide a framework for understanding the molecular basis for the precise temporal control of GABA B signalling by KCTD proteins.
GABA B2 residue Tyr903 (we use human sequence numbering throughout; this residue is equivalent to Tyr902 in the mouse) 13, 16 . We sought to identify a GABA B2 peptide fragment that is capable of binding to a KCTD protein. Using a pull-down assay, we found that a peptide consisting of GABA B2 residues 876-913 could bind to KCTD16 BTB (Fig. 1a and Extended Data Fig. 1a, b) , and we determined the crystal structure of this peptide in complex with KCTD16 BTB to 3.2 Å resolution ( Fig. 1b , Extended Data Table 1 and Extended Data Fig. 2 ).
The structure shows an unusual overall architecture, with KCTD16 BTB adopting an asymmetric pentameric arrangement and wrapping around the GABA B2 C terminus ( Fig. 1b ). Although previous reports had suggested that KCTD16 functions as a tetramer, both our structure and a recently reported peptide-free KCTD16 BTB structure 17 show a pentameric arrangement (Extended Data Fig. 1c ). Over a stretch of roughly 25 amino acids, nearly every side chain in the GABA B2 tail interacts with KCTD16 BTB (Fig. 1b) . Within the interface, KCTD16 BTB residue Phe80 makes particularly extensive contacts with the peptide in each of the five subunits ( Fig. 1c ). Confirming the importance of these interactions, we found that an F80A mutation in KCTD16 BTB caused a complete loss of GABA B2 peptide binding activity in vitro (Extended Data Fig. 1d ), and an equivalent substitution in KCTD12 resulted in loss of GABA B -mediated KCTD12 membrane localization in cells ( Fig. 1d ). Almost all residues in the interaction interface are conserved in all GABA B -regulating KCTD subtypes (KCTD8, KCTD12 and KCTD16), accounting for the specific binding of these KCTDs to GABA B receptors (Extended Data Fig. 1e ).
In addition to binding the GABA B2 tail, KCTDs also interact with Gβγ subunits 4 . In an in vitro pull-down assay using glutathione-S-transferase (GST)-tagged KCTD12, we found that a substochiometric amount of GABA B2 receptor tail but near-stochiometric amounts of Gβ 1 γ 2 heterodimer could be pulled down by KCTD12. By contrast, KCTD12 failed to co-purify Gαβγ heterotrimers irrespective of Gα subtype ( Fig. 2a and Extended Data Fig. 3a, b ). While the KCTD12 BTB domain mediates interaction with the receptor, its C-terminal H1 domain is responsible for desensitization 18 . Consistent with this, we observed that the KCTD12 H1 domain alone was sufficient to bind Gβγ, with an affinity of 185 nM ( Fig. 2b and Extended Data Fig. 3c ). Negative-stain electron-microscopy two-dimensional class averages of the KCTD12 H1 in complex with Gβγ revealed a symmetric pentameric assembly, with the H1-domain pentamer engaging in interaction with five copies of the Gβγ heterodimer ( Fig. 2b and Extended Data Fig. 3d-f ).
To investigate the details of H1-domain interaction with Gβγ in more detail, we determined the crystal structure of the KCTD12 H1 /Gβγ complex to 3.7 Å resolution (Extended Data Table 1 and Extended Data Fig. 2b ). In parallel, we determined a negative-stain electron-microscopy envelope for full-length KCTD12 in complex with Gβγ (Extended Data Fig. 4 ). These data show that the KCTD12 H1 /Gβγ complex is pentameric and displays near-perfect C5 symmetry. KCTD12 H1 possesses a β-propeller-like fold, with each H1 domain comprising a separate blade of the propeller. The propeller is surrounded by a tightly packed ring of Gβγ heterodimers in direct contact with one another. Interactions between KCTD12 and the G protein are confined to the Gβ subunit, with Gγ subunits arrayed peripherally around the edge of the pentameric ring ( Fig. 2c ). Previous reports had suggested that the amino-acid motif NFLEQ in KCTD12 is important for receptor desensitization 18 . However, in our crystal structure this region does not interact with Gβγ subunits, but is instead involved in oligomeric contacts between adjacent KCTD12 subunits (Extended Data Fig. 5a ).
The KCTD12 H1 domain itself consists of a five-stranded antiparallel β-sheet interrupted by two α-helices (Extended Data Fig. 5b ). The five Gβγ subunits each interact with two KCTD12 H1 subunits, which together occlude a large surface on Gβ ( Fig. 3a and Extended Data Fig. 5c ). The loop between the first and second β-strands of KCTD12 H1 includes basic residues that interact with an acidic patch on the Gβ β-propeller (Fig. 3b ); a longer loop in KCTD12 H1 after the first α-helix sits in the groove between the N-terminal helix of Gβ and the β-propeller domain (Fig. 3c ). Mutating residues in the KCTD12 H1 domain in either of these interfaces (R232D or R257D mutations) entirely abolishes G-protein binding (Fig. 3d ). Although both KCTD mutants can localize to the cell membrane in the presence of GABA B receptors (Extended Data Fig. 5d ), they fail to desensitize GABA B -mediated GIRK channel currents ( Fig. 3e, f) . Interestingly, the KCTD-binding site on the surface of Gβγ would partially occlude Gα binding ( Fig. 3g ), but is entirely non-overlapping with the GIRK-channel-binding site 19 (Fig. 3g, h) . Hence, binding of a KCTD12 pentamer to a single Gβγ subunit in complex with GIRK2 could be accommodated with minimal structural rearrangement, although the full 5/5 complex is incompatible owing to extensive clashes between the GIRK2 intracellular domain and other KCTD12-bound Gβγ dimers ( Fig. 3h and Extended Data Fig. 6a, b) .
One of the more remarkable features of the complex is the fact that the Gβγ subunits pack so closely to one another that they interact directly, burying a surface of 351 Å 2 . By contrast, the GIRK channel is bound by four spatially isolated Gβγ subunits (Extended Data Fig. 6a -c). Residues in the Gβ-Gβ interface observed in our structure are highly conserved across species, raising the possibility that this interaction is functionally important. To test this, we incubated KCTD12 H1 with a substoichiometric amount of Gβγ. Under these conditions, only full 5/5 complexes and free KCTD12 were seen with size-exclusion chrom atography, with no evidence of partial oligomers, suggesting that KCTD12 binding to Gβγ is highly cooperative (Extended Data Fig. 6d ). When a single Gβ residue involved in oligomeric Gβ-Gβ contacts was mutated (R42D mutation), we observed a broad 5/5 complex peak and free Gβγ in size-exclusion chromatography. Introduction of a second mutation (R46D) resulted in only partial complex formation (Extended Data Fig. 6e ), further supporting a role of cooperative Gβ-Gβ contacts in KCTD binding.
Gβγ is the key signalling intermediate during GABA B activation of GIRK currents, and in the course of a signalling event a Gβγ subunit interacts sequentially with a series of progressively higher-affinity binding partners. The dissociation constants (K D ) for Gβγ binding Letter reSeArCH to GTP-bound Gα i , GIRK channels, KCTD12 and GDP-bound Gα i are (respectively): undetectable, roughly 250 μM (refs 20,21 ), 185 nM (Extended Data Fig. 3c ), and 3 nM (ref. 22 ). If the affinity of Gβγ for KCTDs is so much higher than its affinity for GIRK channels, how can KCTDs desensitize the channels without preventing their activation in the first place? Clearly, the on-rate for Gβγ association with KCTDs must be lower than that for association with GIRK channels, otherwise Gβγ subunits would be sequestered prematurely. We propose one possible explanation for how this might be achieved.
KCTDs bind at the distal C terminus of the GABA-receptor B2 subunit-roughly 350 Å from the last transmembrane domain-with an intervening, structurally rigid coiled-coil domain. This means that KCTDs can diffuse far from the membrane plane ( Fig. 4) . When the GABA B receptor is activated, Gβγ subunits are liberated from Gα but remain tethered to the membrane because of their lipid anchor, resulting in GIRK channel activation while KCTDs are at a relatively low local concentration. When a KCTD molecule happens to encounter a GIRK-bound Gβγ subunit, it can bind simultaneously, but formation of the oligomeric complex is sterically incompatible with Gβγ binding to GIRK channels. The higher affinity and cooperativity of binding to KCTD may then drive stripping of subsequent Gβγ subunits from GIRKs following an initial encounter, resulting in rapid channel closure. Finally, reassociation of Gβγ with GDP-bound Gα subunits could restore equilibrium and reset the cycle (Extended Data Fig. 7) .
The regulation of GABA B signalling by KCTD proteins is a unique and important means of achieving functional diversity in these critical receptors. Here we show how the KCTD BTB domain recognizes the GABA B2 C terminus to tether a Gβγ-sequestering H1 domain on the receptor's distal tail, providing a means of efficiently deactivating GIRK channels. In this way, KCTDs afford GABA B receptors with tight temporal control of signalling that is not achievable with the slower β-arrestin pathway used to desensitize most GPCRs.
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Protein expression and purification. Human KCTD12 and KCTD16 genes were synthesized by Integrated DNA Technologies. KCTD12 (residues 32-131) and KCTD16 (residues 23-124) BTB domains were cloned into a pET28a expression vector (EMD Millipore) to allow expression of a fusion protein consisting of the KCTD BTB domain plus an N-terminal His 6 -SUMO tag, or expression of an untagged BTB domain, in Escherichia coli strain BL21(DE3). KCTD12 (residues 200-325) and KCTD16 (residues 158-279) H1 domains were cloned into the multiple cloning site 1 of pETduet-1 vector (EMD Millipore) and expressed with an N-terminal His 6 -SUMO tag followed by a 3C protease site. All human GABA B2 C-terminal truncations were cloned into the same vector with an N-terminal His 6 -GST or His 6 -SUMO fusion protein followed by a 3C protease site, and were expressed in BL21(DE3) E. coli. KCTD12 (residues 32-325) and KCTD16 (residues 21-279) constructs containing both BTB and H1 domains were cloned into the pVL1393 vector (Expression Systems) and protein was expressed using baculovirus infection of Sf9 insect cells (Expression Systems) according the manufacturer's protocols. These constructs were expressed with an N-terminal His 6 -GST fusion protein followed by a 3C protease site. Human Gα q was cloned into pVL1393 without tags. Human Gβ 1 γ 2 heterodimer was modified to include an N-terminal His 6 tag on the Gβ subunit and a C68S point mutation in Gγ, which eliminates the lipid-modification site. A bicistronic vector based on pVL1392 was used to prepare baculovirus encoding both subunits. All point mutations and deletions were introduced by the QuikChange method.
Plasmids encoding untagged KCTD16 BTB and His 6 -GST-tagged GABA B2 fragment were co-transformed into E. coli strain BL21(DE3). Bacteria were cultured in LB medium supplemented with 50 μg ml −1 ampicillin and 50 μg ml −1 kanamycin at 37 °C to an optical density (OD) 600 value of 0.8, and protein expression was induced by the addition of 0.5 mM isopropyl 1-thio-β-d-glucopyranoside followed by shaking overnight at 18 °C. Cells were harvested by centrifugation, resuspended in buffer A (50 mM Tris-HCl, pH 8.0, 250 mM NaCl and 25 mM imidazole) and lysed by sonication. His-GST-GABA B2 fragment in complex with KCTD16 BTB was purified from clarified lysate by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography. Resin was washed with buffer A and protein then eluted with buffer B (50 mM Tris-HCl, pH 8.0, 250 mM NaCl and 250 mM imidazole). The eluted fraction was incubated with 3C protease overnight to cleave the His 6 -GST tag. Protein solution was diluted threefold by 20 mM HEPES-NaOH, pH 7.6, and loaded onto a Q sepharose column (GE Healthcare). The flow through was collected, concentrated and further purified by size-exclusion chromatography (SEC) on a Superdex S200 10/300 column equilibrated in storage buffer (10 mM HEPES-NaOH pH 7.6 and 150 mM NaCl). Protein expression and nickel-affinity purification for His 6 -SUMO-tagged KCTD12 H1 was performed as described above. After tag cleavage by 3C protease, the protein sample was concentrated and purified on a Superdex S200 10/300 size-exclusion column equilibrated in storage buffer.
His 6 -GST-tagged KCTD12 residues 32-325 or KCTD16 residues 21-279 was expressed in Sf9 insect cell cultures using the BestBac baculovirus system (Expression Systems). Infection was performed when cells reached a density of 3 × 10 6 cells per ml and flasks were shaken at 27 °C for 36 h before harvest. Cells were harvested by centrifugation and lysed in buffer A using a glass dounce tissue grinder. Protein was purified by Ni-NTA gravity flow chromatography followed by glutathione agarose bead affinity purification (GE Healthcare). The protein was further purified on a Superdex S200 10/300 column equilibrated in storage buffer. His 6 -tagged Gβ 1 and Gγ 2 (C68S mutant) were expressed in Sf9 insect cells using the BestBac system (Expression Systems) as described above. Purification was performed as previously reported 23 .
For assembly and purification of the KCTD12 H1 /Gβ 1 γ 2 complex, individually purified KCTD12 H1 and Gβ 1 γ 2 proteins were mixed in a 1/1.2 molar ratio and then incubated at room temperature for 30 min. Excess Gβ 1 γ 2 was separated from KCTD12 H1/Gβ 1 γ 2 complex on a Superdex S200 10/300 column in binding buffer (20 mM HEPES-NaCl pH 7.6 and 50 mM NaCl). For the KCTD16 21-279/ GABA B2 876-913 complex, purified His 6 -SUMO-tagged GABA B2 876-913 and His 6 -GST-tagged KCTD16 21-279 were mixed in a 2/1 molar ratio. The His 6 -SUMO tag of GABA B2 and His 6 -GST tag of KCTD16 21-279 were cleaved by 3C protease at 4 °C overnight. The protein complex was further purified by SEC S200 10/300 with storage buffer. For the KCTD12 32-325/GABA B2 876-913/Gβ 1 γ 2 complex, individually purified His 6 -GST-tagged KCTD12 32-325, His 6 -SUMO-tagged GABA B2 876-913 and Gβ 1 γ 2 were mixed in a 1/2/1.2 ratio. After tag cleavage with 3C protease, the protein sample was loaded onto a Superdex S200 10/300 column equilibrated in binding buffer. GST pull-down assay. To identify a minimal portion of GABA B2 suitable for binding KCTDs, we cloned a series of GABA B2 C-terminal truncations. His 6 -SMT3tagged KCTD12 or KCTD16 and His 6 -GST-tagged GABA B2 truncation were co-transformed and co-expressed in E. coli strain BL21(DE3). GST pull-down was performed as described 24 . For the interaction analysis, individually purified His 6 -SUMO-tagged GABA B2 876-913 or Gβ 1 γ 2 complex or Gα q β 1 γ 2 complex was added to His 6 -GST-tagged KCTD12 32-325 in an excessive amount in 200 μl of binding buffer. The mixtures were incubated with 20 μl of glutathione-sepharose beads and gently rotated at 4 °C for 1 h. After the beads were washed three times with binding buffer, the bound protein was eluted with 20 μl of binding buffer supplemented with 20 mM glutathione. Input and eluate samples were resolved using SDS-PAGE and stained with Coomassie blue. Crystallization and structure determination. The KCTD16 BTB domain (residues 23-124) and GABA B2 fragment (residues 876-913) were crystallized at 20 °C using the hanging-drop vapour-diffusion method by mixing 0.5 μl of protein (19 mg ml −1 ) and 0.5 μl of reservoir solution containing 100 mM MgCl 2 , 100 mM Tris-HCl pH 7.5 and 12% (w/v) PEG8000. Initial efforts to crystallize the KCTD12 H1 domain in complex with Gβ 1 γ 2 were only successful in wells with fungal contamination. Although these crystals did not diffract, we reasoned that trimming by fungal proteases might be facilitating crystallogenesis. Indeed, strongly diffracting crystals were obtained when purified KCTD12 H1 (residues 200-325) and Gβ 1 γ 2 were mixed in a 1/1.2 molar ratio with a small amount of trypsin (1/1,000 by mass) for 30 min at room temperature before setting trays. Crystals were obtained by the sitting-drop vapour-diffusion method in drops mixed with 100 nl of protein (9 mg ml −1 ) and 100 nl of reservoir solution containing 0.2 M NaCl, 0.1 M sodium cacodylate and 8% (w/v) PEG8000 after overnight growth at 20 °C. The crystals were flash-frozen in liquid nitrogen without additional cryoprotection.
Diffraction data were collected at Advanced Photon Source GM/CA beamlines 23ID-B and 23ID-D with a 20-μm collimated-beam dimension. Data were processed in the HKL2000 software package 25 . Crystals of KCTD16 BTB in complex with the GABA B2 fragment belonged to the P2 1 space group, and contained two copies of the KCTD16 BTB/GABA B2 fragment complex per asymmetric unit. Phase was determined with molecular replacement using Phaser in Phenix 26 with the KCTD16 BTB structure (Protein Data Bank (PDB) identification code 5A15) 17 as a search model. The final refined structure includes two copies of the KCTD16 BTB pentamer with residues 23-124 resolved, and two GABA B2 C-terminal peptides with residues 884-913 resolved. Ramachandran analysis showed that 95.7% of residues are in the favoured regions, and 4.3% in the allowed regions. Crystals for the KCTD12 H1 /Gβ 1 γ 2 complex belong to space group P2 1 2 1 2 1 . The structure was solved by molecular replacement using Phaser in Phenix with the structure of the bovine Gβ 1 γ 2 heterodimer (PDB identification code 1OMW) 27 as a search model. The final model includes one copy of the KCTD12 H1 pentamer (residues 206-324) and five copies of the Gβ 1 γ 2 complex. The model was refined through iterative model building in Coot 28 and reciprocal space refinement in phenix. refine 29 . The final structure has 97.36% and 2.64% of residues in the favoured and allowed regions, respectively, of the Ramachandran plot. Isothermal titration calorimetry. Isothermal titration calorimetry (ITC) experiments were performed with an ITC200 microcalorimeter (Microcal) at 30 °C. Purified KCTD12 H1 and Gβ 1 γ 2 were exchanged to the same buffer (20 mM HEPES-NaCl pH 7.6 and 100 mM NaCl) with a HiTrap Desalting column (GE Healthcare) before titration. We injected 160 μM of Gβ 1 γ 2 via syringe into a sample cell containing 16 μM of KCTD12 H1 . The integrated heat data were analysed using the one-set-of-sites model in Origin according to the manufacturer's instructions. The dissociation constant K D was calculated as 1/association constant (1/K A ). Electron microscopy and three-dimensional reconstruction. For negative staining, 2.5 μl of protein solution consisting of a complex of GABA B2 C-terminal peptide, full-length KCTD12 and Gβ 1 γ 2 at a concentration of about 0.01 mg ml −1 was added to a glow-discharged carbon-coated copper grid (Electron Microscopy Science) and allowed to adsorb for 20 s. Grids were then washed twice with deionized water and stained twice with freshly prepared 0.75% (w/v) uranyl formate. Filter paper was applied to absorb residual liquid between each step.
Images were collected at room temperature using a Philips Tecnai T12 electron microscope equipped with an LaB6 filament and operated at 120 kV. Images were collected at a magnification of 52,000-fold and a defocus value of 1.5 μm on a Gatan 4K charge-coupled-device (CCD) camera using a low-dose collection procedure. Particles were manually picked in Eman2 (ref. 30 ) and two-dimensional class averages were calculated with Relion 31 . Three-dimensional initial model building, three-dimensional classification and refinement were carried out in cisTEM 32 . Imaging of HEK293T cells. Wild-type or mutant KCTD12 was cloned into pCDNA3.1 vector for the expression of an N-terminal protein C (PC-KCTD12) or enhanced green fluorescent protein (eGFP-KCTD12) fusion protein. HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS) and maintained at 37 °C in a 5% CO 2 humidified incubator. Cells were seeded on poly-l-lysine coated 18-mm coverslips 18 h before transfection. Transfections were done using lipofectamine 3000 (Invitrogen) with 0.7 μg per well of eGFP-KCTD12, eGFP-KCTD12(F87A), A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
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The refined coordinates and structure factors for the KCTD16 BTB domain complex with GABAB2 c-terminal peptide are deposited in the protein data bank under accession code 6M8R. Refined coordinates and structure factors for the KCTD12 H1 domain in complex with G beta1 gamma2 are deposited under accession core 6M8S.
